Trial
NCT02773732
Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
—
Condition
Leukemia
Intervention
Ciprofloxacin 750 MG
Why stopped
slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-08-05